Amgen-Sanofi Patent Case Divides Makers of Antibody Drugs ...Middle East

Medscape - News
Amgen's battle with Sanofi and Regeneron at the Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape US patent law and competition among companies that make antibody medicines. Reuters Health Information

Read More Details
Finally We wish PressBee provided you with enough information of ( Amgen-Sanofi Patent Case Divides Makers of Antibody Drugs )

Apple Storegoogle play

Also on site :



Latest News